Bristol Myers Squibb and Johnson & Johnson have said they will stop development of their oral Factor XIa inhibitor milvexian in acute coronary syndrome after a disappointing trial result. The decision ...
Chase officially announced its Q1 2026 cash back categories for the Chase Freedom Flex® and Chase Freedom® (no longer accepting new applicants). Cardholders can activate these bonus cash back ...
Join us on an exhilarating journey from the classroom to the vibrant coral reefs of Sydney, Australia, where a high school ...